Macquarie has recently initiated Agilon Health Inc (AGL) stock to Neutral rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 11, 2024, Bernstein had initiated the ...

Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.35 which represents a slight increase of $0.19 or 8.80% from the prior close of $2.16. The stock opened at $2.15 and ...

RBC Capital analyst Brad Heffern lowered the firm’s price target on Agree Realty (ADC) to $79 from $80 and keeps an Outperform rating on the shares after its 2025 investment volume update. RBC notes ...